Statements (66)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:associated_with |
hypercalcemia
MEN 2 syndrome calcitonin gene RET_proto-oncogene_mutations parathyroid_hormone_abnormalities |
gptkbp:associatedWith |
calcitonin_production
|
gptkbp:behavior |
papillary thyroid carcinoma
|
gptkbp:characterizedBy |
medullary thyroid carcinoma
|
gptkbp:classification |
endocrine tumors
AJCC staging system |
gptkbp:commonName |
other thyroid cancers
|
gptkbp:descendant |
in some cases
|
gptkbp:designatedAs |
stage II cancer
|
gptkbp:diseaseResistance |
imaging studies
variable based on treatment |
gptkbp:documentedIn |
medical literature
|
https://www.w3.org/2000/01/rdf-schema#label |
MTC's Stage II
|
gptkbp:impact |
surgery
|
gptkbp:includes |
clinical trials
lymph node dissection |
gptkbp:influenced |
environmental factors
genetic factors patient age tumor location tumor grade |
gptkbp:involves |
tumor size greater than 1 cm
|
gptkbp:is_characterized_by |
C-cell hyperplasia
|
gptkbp:is_evaluated_by |
gptkb:CT_scan
MRI ultrasound treatment response |
gptkbp:is_monitored_by |
recurrence
oncologist side effects of treatment |
gptkbp:is_part_of |
multidisciplinary care teams
patient care protocols thyroid cancer management cancer staging systems medullary thyroid carcinoma staging thyroid cancer treatment guidelines |
gptkbp:is_recognized_for |
gptkb:American_Thyroid_Association
gptkb:National_Cancer_Institute medical professionals biopsy results fine needle aspiration biopsy |
gptkbp:is_studied_in |
medical researchers
|
gptkbp:is_supported_by |
palliative care
supportive care immunotherapy targeted therapy hormone therapy thyroidectomy |
gptkbp:is_used_in |
medical textbooks
oncology conferences |
gptkbp:isDesignedFor |
cancer treatment centers
|
gptkbp:leads |
metastasis
|
gptkbp:mayHave |
diarrhea
flushing regional lymph nodes |
gptkbp:requires |
radiation therapy
chemotherapy serum calcitonin levels |
gptkbp:symptoms |
difficulty swallowing
hoarseness neck swelling |